Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
US10736865B2 · kind B2 · utility
0Cited by
19References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 12, 2018 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | Oct 12, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.